Bork, K; Gül, D; Dewald, G
Hereditary angio-oedema with normal C1 inhibitor in a family with affected women and men.Br J Dermatol. Bd. 154. H. 3. 2006 S. 542-545
Bork, K
Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutations.Immunol Allergy Clin North Am. Bd. 26. H. 4. 2006 S. 709-24
Longhurst, HJ; Bork, K
Hereditary angioedema: causes, manifestations and treatment.Hosp Med. Bd. 67. H. 12. 2006 S. 654-657
Bork, K; Meng, G; Staubach, P et al.
Hereditary angioedema: new findings concerning symptoms, affected organs, and course.Am J Med. Bd. 119. H. 3. 2006 S. 267-74
Jansen, T; Grabbe, S
Im Schnitt zehn Jahre bis zur richtigen Diagnose. Kennen Sie die Zeichen des Morbus Fabry?MMW Fortschr Med. Bd. 148. H. 48. 2006 S. 46-7
Cichon, S; Martin, L; Hennies, HC et al.
Increased activity if coagulation factor XII (Hageman factor) causes hereditary angioedema type III.Am J Hum Genet. Bd. 79. H. 6. 2006 S. 1098-1104
Weigmann, B; Jarman, ER; Sudowe, S et al.
Induction of regulatory T cells by leflunomide in a murine model of contact allergen sensitivity.J Invest Dermatol. Bd. 126. 2006 S. 1524-1533
Tüttenberg, A; Becker, C; Hüter, E et al.
Induction of strong and persistent MelanA/MART-1-specific immune responses by adjuvant dendritic cell-based vaccination of stage II melanoma patients.Int J Cancer. Bd. 118. 2006 S. 2617-2627
Bellinghausen, I; König, B; Böttcher, I et al.
Inhibition of human allergic T-helper type I immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.Clin Exp Allergy. Bd. 36. H. 12. 2006 S. 1546-1555
Warger, T; Hilf, N; Rechtsteiner, G et al.
Interaction of TLR2 and TLR4 ligands with the N-terminal domain of Gp96 amplifies innate and adaptive immune responses.J Biol Chem. Bd. 281. H. 32. 2006 S. 22545-53